HYB0 Stock Chart & Stats
€132.00
€0.00(0.00%)
At close: 4:00 PM EDT
€132.00
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€115.00 - €159.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€41.82B
Enterprise Value€50.39K
Total Cash (Recent Filing)€551.83B
Total Debt (Recent Filing)€45.09B
Price to Earnings (P/E)28.3
Beta0.84
Next Earnings
Oct 29, 2026EPS Estimate
1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)803.58
Shares Outstanding334,838,000
10 Day Avg. Volume2
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)9.09
Price to Sales (P/S)9.27
P/FCF Ratio39.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.53
Revenue Forecast (FY)€5.72B
Bulls Say, Bears Say
Bulls Say
Strong ProfitabilityHOYA’s consistently high gross and operating margins indicate differentiated products, pricing power, and efficient execution across its businesses. This profitability provides durable resources for product development, market expansion, and resilience when demand conditions become less favorable.
Conservative Balance SheetVery low leverage gives HOYA substantial financial flexibility and limits the burden of interest costs or refinancing needs. Strong returns on equity also indicate effective use of capital, supporting continued investment and shareholder returns without relying heavily on debt.
Robust Cash GenerationOperating cash flow above net income demonstrates healthy earnings conversion, while robust free cash flow supports reinvestment, innovation, acquisitions, and distributions. The latest TTM improvement strengthens the company’s capacity to fund priorities internally across business cycles.
Bears Say
Uneven Revenue GrowthThe uneven revenue trajectory makes the durability of recent acceleration less certain than the company’s profitability profile. Slower annual growth can reduce operating leverage and complicate planning, requiring sustained product innovation and demand execution to maintain momentum.
Free Cash Flow Conversion GapAlthough cash generation is solid, free cash flow below net income indicates that accounting earnings are not converting fully into immediately deployable cash. Persistent reinvestment or working-capital needs could limit capital allocation flexibility and make growth more cash intensive.
Exposure To Technology CyclesHOYA’s precision materials and components business is exposed to customer manufacturing volumes and technology transitions in cyclical electronics and storage markets. Downturns or delayed adoption can pressure demand and create greater earnings variability than its healthcare-linked activities.
HOYA News
HYB0 FAQ
What was HOYA CORPORATION’s price range in the past 12 months?
HOYA CORPORATION lowest stock price was €115.00 and its highest was €159.00 in the past 12 months.
What is HOYA CORPORATION’s market cap?
HOYA CORPORATION’s market cap is €41.82B.
When is HOYA CORPORATION’s upcoming earnings report date?
HOYA CORPORATION’s upcoming earnings report date is Oct 29, 2026 which is in 42 days.
How were HOYA CORPORATION’s earnings last quarter?
HOYA CORPORATION released its earnings results on Jul 31, 2026. The company reported €1.071 earnings per share for the quarter, beating the consensus estimate of €0.989 by €0.082.
Is HOYA CORPORATION overvalued?
According to Wall Street analysts HOYA CORPORATION’s price is currently Overvalued.
Does HOYA CORPORATION pay dividends?
HOYA CORPORATION does not currently pay dividends.
What is HOYA CORPORATION’s EPS estimate?
HOYA CORPORATION’s EPS estimate is 1.06.
How many shares outstanding does HOYA CORPORATION have?
HOYA CORPORATION has 334,838,000 shares outstanding.
What happened to HOYA CORPORATION’s price movement after its last earnings report?
HOYA CORPORATION reported an EPS of €1.071 in its last earnings report, beating expectations of €0.989. Following the earnings report the stock price went up 4.762%.
Which hedge fund is a major shareholder of HOYA CORPORATION?
Currently, no hedge funds are holding shares in DE:HYB0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HOYA Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.15%
12-Months-Change
Fundamentals
Return on Equity
1.01%
Trailing 12-Months
Asset Growth
-6.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
HOYA CORPORATION
Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophthalmic products like eyeglasses and contact lenses to sophisticated medical instruments such as endoscopes, intraocular lenses, laparoscopic surgical tools, and automated endoscope cleaning systems. This segment also supplies various medical-related items, including prosthetic ceramic fillers and metallic implants. Furthermore, HOYA manages Eyecity, a specialized retail chain for contact lenses. Beyond healthcare, the company is a significant contributor to the information technology sector, manufacturing critical components like mask blanks and photomasks for semiconductor and liquid crystal display production, as well as glass disks for hard disk drives. Their imaging product range encompasses optical glasses, lenses, colored glass filters, and laser/UV light resources. Additionally, HOYA develops software solutions, notably ReadSpeaker for speech synthesis, and provides cloud-based services such as Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution.
Technical Analysis
Becton Dickinson
―
Cooper Co
―
Intuitive Surgical
―
Staar Surgical
―
Bausch + Lomb Corporation
―